Corvus Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, engages in the development of product candidates that precisely target proteins that are critical to immune cell maturation and function in the United States. The com...
Q1 2026
May 7, 2026
FY 2025
Mar 12, 2026
Q4 2025
Q3 2025
Nov 4, 2025
Q2 2025
Aug 7, 2025